期刊文献+

轻度认知功能障碍与早期阿尔茨海默病诊断的外周标志 被引量:1

下载PDF
导出
摘要 轻度认知功能障碍作为阿尔茨海默病的前期阶段,有着与阿尔茨海默病不同程度相似的外周标志。这些外周标志的研究进展主要表现在神经心理认知改变、生物学标志 Aβ和 Tau 蛋白以及分子生物学标志 ApoE 等方面;重视轻度认知功能障碍,认识早期阿尔茨海默病外周标志对阿尔茨海默病的早期诊断和早期干预有重要的意义。
作者 司俊霞 谈跃
出处 《国外医学(老年医学分册)》 2005年第6期241-243,共3页 Foreign Medical Sciences(Geriatrics)
基金 云南省教委资助课题(05-206)
  • 相关文献

参考文献9

  • 1Petersen RC, Doody R, Kurz A et al. Current concepts in mild cognitive impairment. Arch Neurol, 2001; 58:1985~ 1992.
  • 2Galluzzis, Cimaschil, Ferrucci L et al. Mild cognitive impairment clinical features and review of screening instrument. Aging Clin Exp Res, 2001; 13:183~202.
  • 3Smith MA, Joseph JA, Atwood CS et al. Predicing the failure of anmyloid - beta vaccine. Lancet, 2002; 359:1864~ 1865.
  • 4Masson C, Leys D, Buce L et al. Cerebral amyloid angiopathies. Press Med, 2000; 29:1717~1722.
  • 5Riemenschneider M, Lautenschlager N, Wagenpfeid S et al. Cerebrospinal fluid tau and β- amyloid42 proteins identify Alzheimer's disease in subjects with mild cognitive impaiment. Ann Neurol, 2002; 59: 1729~ 1734.
  • 6Padovani A, Borroni B, Colciaghi F et al. Abnormalities in the pattern of platelet amyloid precursor protein forms in patients with mild cognitive impairment and Alzheimer's disease. Ann Neurol, 2002; 59:71~75.
  • 7Andreasen N, Vanmechelen E, Vanderstichele H et al.Cerebrospinal fluid levels of total- tau, phospho- tau and Aβ42 predicts dvelopment of Alzheimer's disease in patients with cognitive impairment. Acta Neurol Scand Suppl,2003; 179:47~51.
  • 8de Leon MJ, Segal S, Tarshish CY et al. Longitudinal cerebrospinal fluid tau load increases in mild cognitive impairment. Neurosci Lett, 2002; 333:183~186.
  • 9Choms, Hyman BT, Greenberg SM et al. Quantitation of apoE domains in Alzheimer's disease brain suggests a role for apoE in Aβ aggregation. J Neuropathol Exp Neurol,2001: 60:342~349.

同被引文献20

  • 1张连春,陶华英.轻度认知功能障碍转化为阿尔茨海默病的预测研究[J].医学综述,2007,13(20):1575-1577. 被引量:3
  • 2Petersen RC. Mild cognitive impairment: transition between aging and Alzheimer's disease[J]. Neurologia,2000,15:93-101.
  • 3Tarkowski E, Andreasen N, Tarkowski A, et al. Intrathecalinflammation precedes development of Alzheimer's disease[J]. J Neurol Neurosurg Psychiatry,2003,74:1200-1205.
  • 4Blennow K, Hampel H. CSF markers for incipient Alzheimer's disease[J]. Lancet Neurol,2003,2:605-613.
  • 5Silbert LC, Quinn JF, Moore MM, et al. Changes in premorbid brain volume predict Alzheimer's disease pathology[J]. Neurology, 2003,61:487-492.
  • 6Petersen RC, Smith GE, Waring SC, et al. Mild cognitive impairment: clinical chal=acterization and outcome[J]. Arch Neurol,1999,56:303-308.
  • 7American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders[M]. third edn, revised. Arlington, VA, USA: American Psychiatric Association,1987:|.
  • 8Mckhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer' s Disease[J]. Neurology,1984,34:939-944.
  • 9Mann R, Hewitt CE, Gilbody SM. Assessing the quality of diagnostic studies using psychometric instruments: applying QUADAS[J]. Soc Psychiatry Psychiatr Epidemiol,2009,44:300- 307.
  • 10Herukka SK, Hallikainen M, Soininen H, et al. CSF A~i42 and tau or phosphorylated tau and prediction of progressive mild cognitive impairment [J]. Neurology,2005,64:1294 - 1297.

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部